Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Cancer Research Communications
|
August 28, 2023
Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs
Thomas S Dexheimer, Nathan P Coussens, Thomas Silvers, et al.
Research Square
|
June 5, 2025
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroids
Beverly A Teicher, Thomas S Dexheimer, Thomas Silvers, et al.
Cancer Chemotherapy and Pharmacology
|
September 12, 2025
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroids
Beverly A Teicher, Thomas S Dexheimer, Thomas Silvers, et al.
Experimental and Molecular Pathology
|
June 28, 2025
Polymerase Ѳ inhibitors combinations with approved and investigational agents in patient-derived tumor multi-cell type (mct) spheroids
Beverly A Teicher, Thomas S Dexheimer, Li Chen, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
March 14, 2017
3D Models of the NCI60 Cell Lines for Screening Oncology Compounds
Mike Selby, Rene Delosh, Julie Laudeman, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
April 10, 2025
Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids
Nathan P Coussens, Thomas S Dexheimer, Thomas Silvers, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
October 23, 2025
High-throughput combination screening of Pidnarulex and other G-quadruplex ligands in multi-cell type tumor spheroids
Thomas S Dexheimer, Nathan P Coussens, Thomas Silvers, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
February 25, 2025
Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids
Thomas S Dexheimer, Zahra Davoudi, Nathan P Coussens, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
October 3, 2024
Combination screen in multi-cell type tumor spheroids reveals interaction between aryl hydrocarbon receptor antagonists and E1 ubiquitin-activating enzyme inhibitor
Thomas S Dexheimer, Nathan P Coussens, Thomas Silvers, et al.
Cancer Medicine
|
August 3, 2017
Small cell lung carcinoma cell line screen of etoposide/carboplatin plus a third agent
Beverly A Teicher, Thomas Silvers, Michael Selby, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Cancer Research Communications
|
August 28, 2023
Multicellular Complex Tumor Spheroid Response to DNA Repair Inhibitors in Combination with DNA-damaging Drugs
Thomas S Dexheimer, Nathan P Coussens, Thomas Silvers, et al.
Research Square
|
June 5, 2025
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroids
Beverly A Teicher, Thomas S Dexheimer, Thomas Silvers, et al.
Cancer Chemotherapy and Pharmacology
|
September 12, 2025
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroids
Beverly A Teicher, Thomas S Dexheimer, Thomas Silvers, et al.
Experimental and Molecular Pathology
|
June 28, 2025
Polymerase Ѳ inhibitors combinations with approved and investigational agents in patient-derived tumor multi-cell type (mct) spheroids
Beverly A Teicher, Thomas S Dexheimer, Li Chen, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
March 14, 2017
3D Models of the NCI60 Cell Lines for Screening Oncology Compounds
Mike Selby, Rene Delosh, Julie Laudeman, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
April 10, 2025
Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids
Nathan P Coussens, Thomas S Dexheimer, Thomas Silvers, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
October 23, 2025
High-throughput combination screening of Pidnarulex and other G-quadruplex ligands in multi-cell type tumor spheroids
Thomas S Dexheimer, Nathan P Coussens, Thomas Silvers, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
February 25, 2025
Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids
Thomas S Dexheimer, Zahra Davoudi, Nathan P Coussens, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
October 3, 2024
Combination screen in multi-cell type tumor spheroids reveals interaction between aryl hydrocarbon receptor antagonists and E1 ubiquitin-activating enzyme inhibitor
Thomas S Dexheimer, Nathan P Coussens, Thomas Silvers, et al.
Cancer Medicine
|
August 3, 2017
Small cell lung carcinoma cell line screen of etoposide/carboplatin plus a third agent
Beverly A Teicher, Thomas Silvers, Michael Selby, et al.
Page
of 2